|
KMID : 0869620200370040429
|
|
Journal of Korean Society of Hospital Pharmacists
2020 Volume.37 No. 4 p.429 ~ p.443
|
|
|
Evaluation of Clinical Pharmacist’s Interventions in Hematology
|
|
Yoo Ji-Seon
Lee So-Young
Kim Jae-Song
Son Eun-Sun
Yu Yun-Mi
|
|
|
Abstract
|
|
|
Background : The significance of the pharmacist’s clinical role has been demonstrated through several studies, and its importance is further emphasized through medication therapy management in hematology. Although many hematology clinical pharmacists operate in various hospitals domestically and abroad, few studies have evaluated the value of the pharmacists’ prescription interventions. The only domestic study to analyze the prescription interventions by hematology clinical pharmacists was published in 2014. However, it does not use the current revised classification criteria. Thus, the purpose of this study was to re-examine the prescription interventions of hematology clinical pharmacists in the current clinical context.
Methods : The details of drug-related interventions were studied among patients admitted to a hospital’s hematology department July 2018-June 2019. The intervention cases were analyzed using the Pharmaceutical Care Network Europe (PCNE) version 9.0 criteria to determine the type of prescription interventions, the cause of drug-related problems, and if accepted. The Overhage criteria was applied to assess the significance of the interventions.
Results : A total of 394 cases of drug prescription intervention were identified for analysis. The study results revealed that the most prescription-mediated drugs were antiemetics (15.3%), followed by antibiotics (13.4%), and antifungal agents (10.2%). According to the PCNE, the most frequently observed prescription intervention was “Effect of drug treatment not optimal (36.3%)”. The most frequent cause for the prescription intervention was “No or incomplete drug treatment in spite of existing indication (31.3%)”. The prescription intervention was accepted in 68.5%, of which 94.7% had clinical significance.
Conclusion : This study confirmed that the clinical pharmacist in hematology conducts various and clinically significant
interventions which optimize patient care. Thus, the results affirmed the positive/health-promoting role of the clinical pharmacist and we expect such results to serve as a basis for increasing in awareness of the role and importance of the clinical pharmacist.
|
|
|
KEYWORD
|
|
|
Hematology, Clinical pharmacist, Prescription intervention, Medication therapy management
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|